Evidence map›Paper›PMID 30233203›Full record

ArticleOncoTargets and therapy2018

MicroRNA 628 suppresses migration and invasion of breast cancer stem cells through targeting SOS1.

Chenghui Lin, Bin Gao, Xuemao Yan, Zixiong Lei, Kebing Chen, Yuquan Li, Qing Zeng, Zeqin Chen, Haomiao Li

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Targeting Breast Cancer Stem Cells.International journal of biological sciences · 2023
    Review
  4. Article
  5. Review
  6. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer.Journal of experimental & clinical cancer research : CR · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Long non-coding RNA LINC01268 promotes cell growth and inhibits cell apoptosis by modulating miR-217/SOS1 axis in acute myeloid leukemia.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
  19. Review
  20. Anti-placental growth factor antibody ameliorates hyperoxia-mediated impairment of lung development in neonatal rats.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chenghui LinDepartment of Medical oncology, TangXia Hospital of DongGuan, DongGuan, P.R. China.
Bin GaoDepartment of Orthopedics, TangXia Hospital of DongGuan, DongGuan, P.R. China.
Xuemao YanDepartment of Orthopedics, TangXia Hospital of DongGuan, DongGuan, P.R. China.
Zixiong LeiDepartment of Musculoskeletal Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, P.R. China, lihaom@mail.sysu.edu.cn.
Kebing ChenDepartment of Musculoskeletal Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, P.R. China, lihaom@mail.sysu.edu.cn.
Yuquan LiDepartment of Orthopedics, TangXia Hospital of DongGuan, DongGuan, P.R. China.
Qing ZengDepartment of Orthopedics, TangXia Hospital of DongGuan, DongGuan, P.R. China.
Zeqin ChenDepartment of Orthopedics, TangXia Hospital of DongGuan, DongGuan, P.R. China.
Haomiao LiDepartment of Musculoskeletal Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, P.R. China, lihaom@mail.sysu.edu.cn.
Tang Hospital · CNThird Affiliated Hospital of Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study is to evaluate the effects of miR-628 on migration and invasion of breast cancer stem cells (CSCs), which are essential for tumor recurrence and metastasis. MATERIALS AND

methodsQuantitative reverse transcription-polymerase chain reaction was used to determine the expression of microRNAs and mRNAs. A subpopulation of CD44

resultsCompared with primary breast cancer cells, bone metastatic breast cancer cells showed significant downregulation of

conclusionmiR-628 suppressed migration and invasion of breast CSCs of MDA-MB-231 and MCF-7 cells by directly targeting SOS1. Enhancement of miR-628 expression might be an effective strategy for managing breast cancer metastasis.

Indexed as

breast cancer stem cellsCD44+/CD24−invasionmigrationmiR-628SOS1

Identifiers

PMID30233203
PMCPMC6129021
OpenAlexW2889501576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.